MAYFIELD VILLAGE, OHIO, May 20, 2026 (GLOBE NEWSWIRE) — The Progressive Corporation (NYSE:PGR) today reported the following results for the month ended April 30, 2026:  April(millions, except per share amounts and ratios; unaudited)   2026       2025     ChangeNet premiums written $ 7,278     $ 6,837     6 %Net premiums earned $ 7,112     $ 6,641     7 %Net income $ 1,087     $ 986     10 %Per share available to common shareholders $ 1.86     $ 1.68     11 %Total pretax net realized gains (losses) on securities $ 402     $ (3 )   NM  Combined ratio   90.2       84.9     5.3 pts.Average diluted equivalent common shares   585.3       587.7     0 %NM = Not Meaningful                April 30,(thousands; unaudited) 2026   2025   % ChangePolicies in Force          Personal Lines          Agency...

ATHENS, Greece, May 20, 2026 (GLOBE NEWSWIRE) — EuroDry Ltd. (NASDAQ: EDRY, the “Company” or “EuroDry”), an owner and operator of drybulk vessels and provider of seaborne transportation for drybulk cargoes, announced today its results for the three-month period ended March 31, 2026. First Quarter 2026 Highlights:Total net revenues of $12.8 million.Net income attributable to controlling shareholders, of $0.26 million or $0.09 earnings per share attributable to controlling shareholders basic and diluted.Adjusted net income1 attributable to controlling shareholders for the quarter of $0.33 million or $0.12 earnings per share attributable to controlling shareholders basic and diluted, which represents the net income attributable to controlling shareholders excluding the unrealized loss on derivatives.Adjusted EBITDA1 was $4.9...

BRANFORD, Conn., May 20, 2026 (GLOBE NEWSWIRE) — Sachem Capital Corp. (NYSE American: SACH) (“Sachem” or the “Company”), a real estate lender specializing in originating, underwriting, funding, servicing, and managing a portfolio of loans secured by first mortgages on real property, today announced its financial results for the quarter ended March 31, 2026. John Villano, CPA, Sachem’s Chief Executive Officer, commented, “During the first quarter, we remained focused on disciplined capital and liquidity management, continuing the strategic priorities established last year. We made meaningful progress resolving legacy loan issues and protecting invested capital, positioning the Company for improved operating performance and future growth. Subsequent to quarter end, we announced a transformational combination transaction with Industrial...

IMVT-1402 showed clinically meaningful response rates of 72.7% ACR20, 54.5% ACR50 and 35.8% ACR70 at Week 16 in the open label period of its trial in difficult-to-treat rheumatoid arthritis (D2T RA); Immunovant will provide further updates on this program in the second half of calendar year 2026 IMVT-1402 proof-of-concept trial in cutaneous lupus erythematosus (CLE) fully enrolled with topline data expected in the second half of calendar year 2026 All other clinical development timelines remain on track for IMVT-1402, including potentially registrational studies in Graves’ disease (GD), myasthenia gravis (MG), chronic inflammatory demyelinating polyneuropathy (CIDP) and Sjögren’s disease (SjD) Current cash balance provides runway to the potential launch of IMVT-1402 in GD Roivant will host a live conference call and webcast at 8:00 a.m....

IMVT-1402 showed clinically meaningful response rates of 72.7% ACR20, 54.5% ACR50 and 35.8% ACR70 at Week 16 in the open label period of its trial in difficult-to-treat rheumatoid arthritis (D2T RA); Immunovant will provide further updates on this program in the second half of calendar year 2026Brepocitinib granted Breakthrough Therapy Designation for the treatment of cutaneous sarcoidosis (CS) based on positive Phase 2 data; potentially registrational trial of brepocitinib in lichen planopilaris (LPP) enrolled its first subjects in March 2026Commercial launch of brepocitinib in dermatomyositis (DM) is expected by the end of September 2026, and topline Phase 3 data for brepocitinib in non-infectious uveitis (NIU) is expected in the second half of calendar year 2026IMVT-1402 proof-of-concept trial in cutaneous lupus erythematosus...

Key First Quarter reported data points:Revenue of $12.2 million, -19.0% vs. Q1 2025 GAAP net income from continuing operations of $343 thousand vs. $254 thousand in Q1 2025 GAAP net income from continuing operations per fully diluted share of $0.006 vs. $0.005 in Q1 2025 Non-GAAP adjusted EBITDA of $441 thousand vs. $593 thousand in Q1 2025BROADVIEW, Ill., May 20, 2026 (GLOBE NEWSWIRE) — Innovative Food Holdings, Inc. (OTCQB: IVFH) (“IVFH,” the “Company,” “we,” “our” or “us”), a national seller of gourmet specialty foods to professional chefs, today reported financial results for the quarter ended March 31, 2026. For the first quarter of 2026, revenue was $12.2 million compared with $15.0 million in the prior-year period. The revenue decline reflected known transition-related and competitive headwinds across Digital Channels,...

SHANGHAI, China, May 20, 2026 (GLOBE NEWSWIRE) — GDS Holdings Limited (“GDS Holdings”, “GDS” or the “Company”) (NASDAQ: GDS; HKEX: 9698), a leading developer and operator of high-performance data centers in China, today announced its unaudited financial results for the first quarter ended March 31, 2026. First Quarter 2026 Financial HighlightsNet revenue increased by 23.6% year-over-year (“Y-o-Y”) to RMB3,367.1 million (US$488.1 million) in the first quarter of 2026 (1Q2025: RMB2,723.2 million). Net revenue excluding some one-time items was RMB2,938.0 million (US$425.9 million), an increase of 7.9% Y-o-Y. Net income increased by 247.1% Y-o-Y to RMB2,652.1 million (US$384.5 million) in the first quarter of 2026 (1Q2025: RMB764.1 million). Net income margin was 78.8% in the first quarter of 2026 (1Q2025: 28.1%). Adjusted EBITDA...

BEIJING, May 20, 2026 (GLOBE NEWSWIRE) — KANZHUN LIMITED (“BOSS Zhipin” or the “Company”) (Nasdaq: BZ; HKEX: 2076), a leading online recruitment platform in China, today announced its unaudited financial results for the quarter ended March 31, 2026. First quarter 2026 HighlightsTotal paid enterprise customers1 in the twelve months ended March 31, 2026 were 7.1 million, an increase of 10.9% from 6.4 million in the twelve months ended March 31, 2025. Average monthly active users2 for the first quarter of 2026 were 60.9 million, an increase of 5.7% from 57.6 million for the same quarter of 2025. Revenues for the first quarter of 2026 were RMB2,068.8 million (US$299.9 million), an increase of 7.6% from RMB1,923.3 million for the same quarter of 2025. Income from operations for the first quarter of 2026 was RMB623.6 million (US$90.4...

First Quarter financial summary(in thousands of $) Q1 2026 Q1 2025 % ChangeNet income attributable to Golar LNG Ltd 83,578 8,197 920%Total operating revenues 137,554 62,502 120%Adjusted EBITDA 1 105,576 40,936 158%Golar’s share of contractual debt 1 2,705,245 1,494,615 81%Recent highlightsGolar LNG Limited (“Golar” or “the Company”) reports Q1 2026 net income attributable to Golar of $84 million inclusive of $37 million of non-cash items1, Adjusted EBITDA1 of $106 million and Total Golar Cash1 of $1.0 billion.FLNG Hilli offloaded 150th cargo.FLNG Gimi overproduced 19% compared to contractual committed volume.MKII construction on time and on budget.Southern Energy S.A. (“SESA”) and Securing Energy for Europe (“SEFE”) sign an 8-year LNG supply agreement for up to two million tonnes of LNG per annum,...